Chemed (NYSE: CHE) director awarded 386 shares of company stock

Rhea-AI Filing Summary

WALSH GEORGE J III reported acquisition or exercise transactions in this Form 4 filing.

CHEMED CORP director WALSH GEORGE J III reported a stock award of 386 shares of Capital Stock. The shares were granted at a reported price of $440.77 per share as a compensation-related award. Following this grant, he directly holds 3,709 shares. A separate entry shows indirect ownership of 434 shares held by his spouse, reflecting family holdings rather than a new market trade.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider WALSH GEORGE J III

Role null

Type	Security	Shares	Price	Value
Grant/Award	Capital Stock	386	$440.77	$170K
holding	Capital Stock	--	--	--

Holdings After Transaction: Capital Stock — 3,709 shares (Direct, null); Capital Stock — 434 shares (Indirect, spouse)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant size: 386 shares Grant price: $440.77 per share Direct holdings after grant: 3,709 shares +1 more

4 metrics

Stock grant size 386 shares Capital Stock award to director on May 18, 2026

Grant price $440.77 per share Reported price for 386-share stock award

Direct holdings after grant 3,709 shares Total CHEMED CORP Capital Stock held directly post-transaction

Indirect spouse holdings 434 shares Capital Stock held indirectly through spouse, reported as holding entry

Key Terms

Grant, award, or other acquisition, Capital Stock, indirect, spouse, +1 more

5 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Capital Stock financial

"security_title: Capital Stock"

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

indirect financial

"ownership_type: indirect"

spouse financial

"nature_of_ownership: spouse"

Award of stock financial

"footnote: Award of stock"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WALSH GEORGE J III

(Last) (First) (Middle)

2600 CHEMED CENTER

255 EAST 5TH STREET

(Street)

CINCINNATI OHIO 45202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	05/18/2026		A		386	A(1)	$440.77	3,709	D
Capital Stock								434	I	spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award of stock

	George J. Walsh	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did CHEMED CORP (CHE) director George J. Walsh III report in this Form 4?

Director George J. Walsh III reported receiving a grant of 386 shares of CHEMED CORP Capital Stock. The award was recorded at $440.77 per share and classified as a grant, award, or other acquisition rather than an open-market purchase or sale.

Was the CHEMED CORP Form 4 transaction a stock purchase or a grant?

The Form 4 shows a stock grant, not an open-market purchase. Walsh received 386 shares as an “Award of stock,” coded as a grant, award, or other acquisition, reflecting equity compensation rather than a discretionary market trade in CHEMED CORP shares.

How many CHEMED CORP shares does George J. Walsh III hold after this reported grant?

After the grant, Walsh directly holds 3,709 CHEMED CORP shares. The Form 4 also lists 434 shares held indirectly through his spouse, indicating additional family ownership separate from his directly registered position in the company’s Capital Stock.

What price per share was used for the CHEMED CORP stock award to George J. Walsh III?

The reported price for the 386-share stock award was $440.77 per CHEMED CORP share. This price is used for reporting the grant’s value on the Form 4 and does not necessarily indicate an open-market trading price at the time.

Does the CHEMED CORP Form 4 show any stock sales by George J. Walsh III?

The Form 4 does not report any stock sales by Walsh. It records a single compensation-related acquisition of 386 shares and a separate holding entry for 434 shares owned indirectly through his spouse, without any open-market sale transactions disclosed.